| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |